Literature DB >> 31178166

Partial and radical nephrectomy in children, adolescents, and young adults: Equivalent readmissions and postoperative complications.

M Hassan Alkazemi1, Zachary R Dionise1, Ruiyang Jiang1, Steven Wolf2, Gina-Maria Pomann2, Elisabeth T Tracy3, Henry E Rice3, Jonathan C Routh4.   

Abstract

OBJECTIVES: To compare and contrast the use of partial nephrectomy (PN) and radical nephrectomy (RN) in pediatric malignant renal tumors using a nationally representative database.
METHODS: The 2010-2014 Nationwide Readmissions Database (NRD) was used to obtain PN and RN select postoperative data. ICD-9-CM codes were used to identify children (<10 years), adolescents (10-19 years) and young adults (20-30 years) diagnosed with malignant renal tumors who were treated with a PN or RN. The presence of a 30-day readmission, occurrence of postoperative complications, cost, and length of stay (LOS) were studied and weighted logistic regression models were fit to test for associations.
RESULTS: There were 4330 weighted encounters (1289 PNs, 3041 RNs) that met inclusion criteria: 50.8% were children, 7.2% were adolescents, and 42% were young adults. Young adults had the highest rates of PN, whereas children had the highest rates of RN (p < 0.0001). Overall, no evidence was found to suggest a difference in odds between surgical modality and the presence of a 30-day readmission or postoperative complication. While PN was on average $9000 cheaper compared to RN overall, its cost was similar to that of RN for children. Similarly, PN patients had a shorter overall LOS compared to RN patients, but their LOS was similar to that of children who underwent RN.
CONCLUSION: There was no evidence of a difference in odds between RN and PN in terms of postoperative readmissions or in-hospital complication rates. Additionally, we observed descriptive differences in both cost and LOS between the surgical modalities across age groups. TYPE OF STUDY: Retrospective comparative study (administrative database analysis). LEVEL OF EVIDENCE: Level III.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Partial nephrectomy; Postoperative complications; Radical nephrectomy; Wilms tumor

Mesh:

Year:  2019        PMID: 31178166      PMCID: PMC6879817          DOI: 10.1016/j.jpedsurg.2019.05.018

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  28 in total

1.  Complications of radical and partial nephrectomy in a large contemporary cohort.

Authors:  Andrew J Stephenson; A Ari Hakimi; Mark E Snyder; Paul Russo
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

Review 2.  Nephron-sparing surgery for Wilms tumor: A systematic review.

Authors:  Rand N Wilcox Vanden Berg; Emily N Bierman; Megan Van Noord; Henry E Rice; Jonathan C Routh
Journal:  Urol Oncol       Date:  2015-08-05       Impact factor: 3.498

3.  Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy.

Authors:  Rodrigo B Interiano; Noel Delos Santos; Sujuan Huang; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Daniel M Green; Andrew M Davidoff
Journal:  Cancer       Date:  2015-04-01       Impact factor: 6.860

4.  The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program.

Authors:  S F Khuri; J Daley; W Henderson; K Hur; J Demakis; J B Aust; V Chong; P J Fabri; J O Gibbs; F Grover; K Hammermeister; G Irvin; G McDonald; E Passaro; L Phillips; F Scamman; J Spencer; J F Stremple
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

5.  A novel multispecialty surgical risk score for children.

Authors:  Daniel Rhee; Jose H Salazar; Yiyi Zhang; Jingyan Yang; Jessica Yang; Dominic Papandria; Gezzer Ortega; Adam B Goldin; Shawn J Rangel; Kristin Chrouser; David C Chang; Fizan Abdullah
Journal:  Pediatrics       Date:  2013-02-04       Impact factor: 7.124

6.  Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors.

Authors:  R Houston Thompson; Sameer Siddiqui; Christine M Lohse; Bradley C Leibovich; Paul Russo; Michael L Blute
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

7.  Diffusion of surgical innovation among patients with kidney cancer.

Authors:  David C Miller; Christopher S Saigal; Mousumi Banerjee; Jan Hanley; Mark S Litwin
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

8.  Overall Survival and Renal Function of Patients With Synchronous Bilateral Wilms Tumor Undergoing Surgery at a Single Institution.

Authors:  Andrew M Davidoff; Rodrigo B Interiano; Lynn Wynn; Noel Delos Santos; Jeffrey S Dome; Daniel M Green; Rachel C Brennan; M Beth McCarville; Matthew J Krasin; Kathleen Kieran; Mark A Williams
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

9.  Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.

Authors:  Hsin-Hsiao S Wang; Michael R Abern; Nicholas G Cost; David I Chu; Sherry S Ross; John S Wiener; Jonathan C Routh
Journal:  J Urol       Date:  2014-04-13       Impact factor: 7.450

10.  Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.

Authors:  Paras H Shah; Daniel M Moreira; Zhamshid Okhunov; Vinay R Patel; Sameer Chopra; Aria A Razmaria; Manaf Alom; Arvin K George; Oksana Yaskiv; Michael J Schwartz; Mihir Desai; Manish A Vira; Lee Richstone; Jaime Landman; Arieh L Shalhav; Inderbir Gill; Louis R Kavoussi
Journal:  J Urol       Date:  2016-02-19       Impact factor: 7.600

View more
  1 in total

1.  Open versus minimally-invasive surgical techniques in pediatric renal tumors: A population-level analysis of in-hospital outcomes.

Authors:  Kirsten L Simmons; Jason C Chandrapal; Steven Wolf; Henry E Rice; Elisabeth E Tracy; Tamara Fitzgerald; Gina-Maria Pomann; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2021-03-19       Impact factor: 1.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.